EDAP TMS S.A Net Profit Margin 2010-2024 | EDAP
EDAP TMS S.A net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| EDAP TMS S.A Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-12-31 |
$0.07B |
$-0.02B |
-30.43% |
| 2024-09-30 |
$0.07B |
$-0.02B |
-35.29% |
| 2024-06-30 |
$0.07B |
$-0.02B |
-31.34% |
| 2024-03-31 |
$0.07B |
$-0.02B |
-28.79% |
| 2023-12-31 |
$0.07B |
$-0.02B |
-33.33% |
| 2023-09-30 |
$0.06B |
$-0.02B |
-36.07% |
| 2023-06-30 |
$0.06B |
$-0.02B |
-30.00% |
| 2023-03-31 |
$0.06B |
$-0.01B |
-18.64% |
| 2022-12-31 |
$0.06B |
$0.00B |
-5.17% |
| 2022-09-30 |
$0.06B |
$0.00B |
6.90% |
| 2022-06-30 |
$0.06B |
$0.00B |
5.26% |
| 2022-03-31 |
$0.05B |
0 |
0.00% |
| 2021-12-31 |
$0.05B |
$0.00B |
1.96% |
| 2021-09-30 |
$0.05B |
0 |
0.00% |
| 2021-06-30 |
$0.05B |
0 |
0.00% |
| 2021-03-31 |
$0.05B |
$0.00B |
1.96% |
| 2020-12-31 |
$0.05B |
$0.00B |
-2.13% |
| 2020-09-30 |
$0.04B |
$0.00B |
-7.14% |
| 2020-06-30 |
$0.04B |
$0.00B |
-2.38% |
| 2020-03-31 |
$0.05B |
$0.00B |
2.17% |
| 2019-12-31 |
$0.05B |
$0.00B |
4.00% |
| 2019-09-30 |
$0.05B |
$0.00B |
7.69% |
| 2019-06-30 |
$0.05B |
$0.00B |
4.00% |
| 2019-03-31 |
$0.05B |
$0.00B |
-2.17% |
| 2018-12-31 |
$0.05B |
$0.00B |
-2.22% |
| 2018-09-30 |
$0.04B |
$0.00B |
-4.76% |
| 2018-06-30 |
$0.04B |
$0.00B |
-4.88% |
| 2018-03-31 |
$0.04B |
$0.00B |
-7.32% |
| 2017-12-31 |
$0.04B |
$0.00B |
-2.56% |
| 2017-09-30 |
$0.04B |
$0.00B |
-5.13% |
| 2017-06-30 |
$0.04B |
0 |
0.00% |
| 2017-03-31 |
$0.04B |
$0.01B |
12.82% |
| 2016-12-31 |
$0.04B |
$0.01B |
12.50% |
| 2016-09-30 |
$0.04B |
$0.01B |
29.27% |
| 2016-06-30 |
$0.04B |
$0.01B |
15.38% |
| 2016-03-31 |
$0.04B |
$0.00B |
10.26% |
| 2015-12-31 |
$0.04B |
$0.00B |
-2.78% |
| 2015-09-30 |
$0.03B |
$-0.01B |
-32.26% |
| 2015-06-30 |
$0.03B |
$0.00B |
12.12% |
| 2015-03-31 |
$0.03B |
$0.00B |
-12.50% |
| 2014-12-31 |
$0.04B |
$0.00B |
0.00% |
| 2014-09-30 |
$0.04B |
$0.00B |
5.13% |
| 2014-06-30 |
$0.04B |
$-0.01B |
-18.92% |
| 2014-03-31 |
$0.04B |
0 |
0.00% |
| 2013-12-31 |
$0.03B |
$-0.01B |
-18.75% |
| 2013-09-30 |
$0.03B |
$-0.01B |
-18.18% |
| 2013-06-30 |
$0.03B |
$-0.01B |
-21.21% |
| 2013-03-31 |
$0.04B |
$-0.01B |
-28.57% |
| 2012-12-31 |
$0.03B |
$-0.01B |
-26.47% |
| 2012-09-30 |
$0.03B |
$-0.01B |
-28.13% |
| 2012-06-30 |
$0.03B |
$-0.01B |
-20.59% |
| 2012-03-31 |
$0.03B |
$-0.01B |
-18.75% |
| 2011-12-31 |
$0.03B |
$0.00B |
-6.25% |
| 2011-09-30 |
$0.03B |
$-0.01B |
-33.33% |
| 2011-06-30 |
$0.03B |
$-0.01B |
-45.16% |
| 2011-03-31 |
$0.03B |
$-0.01B |
-39.39% |
| 2010-12-31 |
$0.03B |
$-0.02B |
-53.13% |
| 2010-09-30 |
$0.03B |
$-0.01B |
-15.15% |
| 2010-06-30 |
$0.03B |
$-0.01B |
-33.33% |
| 2010-03-31 |
$0.03B |
$-0.01B |
-32.35% |
| 2009-12-31 |
$0.04B |
$-0.01B |
-31.43% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.082B |
$0.069B |
|
EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors.
|
